These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18838947)

  • 1. Inhibition of ceramide biosynthesis ameliorates pathological consequences of spinal cord injury.
    Cuzzocrea S; Deigner HP; Genovese T; Mazzon E; Esposito E; Crisafulli C; Di Paola R; Bramanti P; Matuschak G; Salvemini D
    Shock; 2009 Jun; 31(6):634-44. PubMed ID: 18838947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of dexamethasone and etanercept reduces secondary damage in experimental spinal cord trauma.
    Genovese T; Mazzon E; Crisafulli C; Esposito E; Di Paola R; Muià C; Di Bella P; Meli R; Bramanti P; Cuzzocrea S
    Neuroscience; 2007 Nov; 150(1):168-81. PubMed ID: 17945432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of endogenous interleukin-10 enhances secondary inflammatory process after spinal cord compression injury in mice.
    Genovese T; Esposito E; Mazzon E; Di Paola R; Caminiti R; Bramanti P; Cappelani A; Cuzzocrea S
    J Neurochem; 2009 Mar; 108(6):1360-72. PubMed ID: 19183262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory effects of etanercept in an experimental model of spinal cord injury.
    Genovese T; Mazzon E; Crisafulli C; Di Paola R; Muià C; Bramanti P; Cuzzocrea S
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1006-16. PubMed ID: 16303916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of FeTSPP, a peroxynitrite decomposition catalyst, in a mouse model of spinal cord injury.
    Genovese T; Mazzon E; Esposito E; Muià C; Di Paola R; Bramanti P; Cuzzocrea S
    Free Radic Biol Med; 2007 Sep; 43(5):763-80. PubMed ID: 17664140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory and anti-apoptotic effects of fumonisin B1, an inhibitor of ceramide synthase, in a rodent model of splanchnic ischemia and reperfusion injury.
    Cuzzocrea S; Di Paola R; Genovese T; Mazzon E; Esposito E; Crisafulli C; Bramanti P; Salvemini D
    J Pharmacol Exp Ther; 2008 Oct; 327(1):45-57. PubMed ID: 18612046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of tyrosine kinase-mediated cellular signalling by Tyrphostins AG126 and AG556 modulates secondary damage in experimental spinal cord trauma.
    Genovese T; Mazzon E; Esposito E; Muià C; Di Paola R; Crisafulli C; Bramanti P; Cuzzocrea S
    Neuropharmacology; 2007 Jun; 52(7):1454-71. PubMed ID: 17418876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of treatment with verbascoside, biotechnologically produced by Syringa vulgaris plant cell cultures in an experimental mice model of spinal cord trauma.
    Genovese T; Paterniti I; Mazzon E; Esposito E; Di Paola R; Galuppo M; Bramanti P; Cuzzocrea S
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Oct; 382(4):331-45. PubMed ID: 20799028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPAR-alpha modulate the anti-inflammatory effect of glucocorticoids in the secondary damage in experimental spinal cord trauma.
    Genovese T; Esposito E; Mazzon E; Crisafulli C; Paterniti I; Di Paola R; Galuppo M; Bramanti P; Cuzzocrea S
    Pharmacol Res; 2009 May; 59(5):338-50. PubMed ID: 19416634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the role of mitogen-activated protein kinase signaling pathways in the development of spinal cord injury.
    Genovese T; Esposito E; Mazzon E; Muià C; Di Paola R; Meli R; Bramanti P; Cuzzocrea S
    J Pharmacol Exp Ther; 2008 Apr; 325(1):100-14. PubMed ID: 18180375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-alpha blockage in a mouse model of SCI: evidence for improved outcome.
    Genovese T; Mazzon E; Crisafulli C; Di Paola R; Muià C; Esposito E; Bramanti P; Cuzzocrea S
    Shock; 2008 Jan; 29(1):32-41. PubMed ID: 17621255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma.
    Genovese T; Mazzon E; Muià C; Patel NS; Threadgill MD; Bramanti P; De Sarro A; Thiemermann C; Cuzzocrea S
    J Pharmacol Exp Ther; 2005 Feb; 312(2):449-57. PubMed ID: 15452194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The critical role of spinal ceramide in the development of partial sciatic nerve ligation-induced neuropathic pain in mice.
    Kobayashi Y; Kiguchi N; Maeda T; Ozaki M; Kishioka S
    Biochem Biophys Res Commun; 2012 May; 421(2):318-22. PubMed ID: 22503971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective adenosine A(2a) receptor agonists reduce the apoptosis in an experimental model of spinal cord trauma.
    Genovese T; Melani A; Esposito E; Paterniti I; Mazzon E; Di Paola R; Bramanti P; Linden J; Pedata F; Cuzzocrea S
    J Biol Regul Homeost Agents; 2010; 24(1):73-86. PubMed ID: 20385073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone reduces severity of experimental spinal cord injury.
    Genovese T; Mazzon E; Esposito E; Muià C; Di Paola R; Crisafulli C; Bramanti P; Cuzzocrea S
    Shock; 2007 Mar; 27(3):258-65. PubMed ID: 17304106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen synthase kinase-3 beta inhibition reduces secondary damage in experimental spinal cord trauma.
    Cuzzocrea S; Genovese T; Mazzon E; Crisafulli C; Di Paola R; Muià C; Collin M; Esposito E; Bramanti P; Thiemermann C
    J Pharmacol Exp Ther; 2006 Jul; 318(1):79-89. PubMed ID: 16601144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gangliosides link the acidic sphingomyelinase-mediated induction of ceramide to 12-lipoxygenase-dependent apoptosis of neuroblastoma in response to fenretinide.
    Lovat PE; Di Sano F; Corazzari M; Fazi B; Donnorso RP; Pearson AD; Hall AG; Redfern CP; Piacentini M
    J Natl Cancer Inst; 2004 Sep; 96(17):1288-99. PubMed ID: 15339967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of inflammatory response after spinal cord trauma with deferoxamine, an iron chelator.
    Paterniti I; Mazzon E; Emanuela E; Paola RD; Galuppo M; Bramanti P; Cuzzocrea S
    Free Radic Res; 2010 Jun; 44(6):694-709. PubMed ID: 20370565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fasudil, a selective inhibitor of Rho kinase activity, in the secondary injury associated with the experimental model of spinal cord trauma.
    Impellizzeri D; Mazzon E; Paterniti I; Esposito E; Cuzzocrea S
    J Pharmacol Exp Ther; 2012 Oct; 343(1):21-33. PubMed ID: 22733360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [TNF-induced apoptosis and necrosis in myeloleukemia cells HL-60 is regulated by reactive oxygen metabolites depending on a cell cycle phase].
    Martynova EA; Poddubskaia EV; Polosukhina EP; Klimova SV
    Biomed Khim; 2003; 49(1):35-45. PubMed ID: 14569872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.